These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 683331)

  • 1. Selective inhibitors of biosynthesis of aminergic neurotransmitters.
    Kollonitsch J; Perkins LM; Patchett AA; Doldouras GA; Marburg S; Duggan DE; Maycock AL; Aster SD
    Nature; 1978 Aug; 274(5674):906-8. PubMed ID: 683331
    [No Abstract]   [Full Text] [Related]  

  • 2. Peptide inhibition of mammalian histidine decarboxylase.
    Hammar L; Ragnarsson U
    Agents Actions; 1979 Oct; 9(4):314-8. PubMed ID: 117688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-action relationships of histidine decarboxylase inhibitors.
    Mole KH; Shepherd DM; Watkins JW
    Arch Int Pharmacodyn Ther; 1975 Aug; 216(2):192-6. PubMed ID: 1237275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of histidine decarboxylase. Derivatives of histidine.
    Kelley JL; Miller CA; White HL
    J Med Chem; 1977 Apr; 20(4):506-9. PubMed ID: 850236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and in vitro effects of GAD and GABA-T inhibitors on AADC activity and of AADC inhibitors on GAD.
    Giorgi O; Rubio MC
    Gen Pharmacol; 1981; 12(4):217-23. PubMed ID: 7250670
    [No Abstract]   [Full Text] [Related]  

  • 6. Specificity in enzyme inhibition. 2. -Aminohydroxamic acids as inhibitors of histidine decarboxylase and 3,4-dihydroxyphenylalanine decarboxylase.
    Smissman EE; Warner VD
    J Med Chem; 1972 Jun; 15(6):681-2. PubMed ID: 5030938
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of histidine decarboxylase by imidazole derivatives.
    Kelley JL; McLean EW; Miller CA
    J Pharm Sci; 1981 Mar; 70(3):341-3. PubMed ID: 7264907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the enantiomers of 5-hexyne-1,4-diamine on ODC, GAD and GABA-T activities in the rat.
    Danzin C; Casara P; Claverie N; Grove J
    Biochem Pharmacol; 1983 Mar; 32(5):941-2. PubMed ID: 6838643
    [No Abstract]   [Full Text] [Related]  

  • 9. cis- and trans-Aconitic acids as inhibitors of glutamate decarboxylase.
    Endo A; Kitahara N
    Hoppe Seylers Z Physiol Chem; 1977 Oct; 358(10):1365-8. PubMed ID: 924365
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of nucleotides and other inhibitors on the inactivation of glutamate decarboxylase.
    Martin DL; Martin SB
    J Neurochem; 1982 Oct; 39(4):1001-8. PubMed ID: 7119776
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential histidine decarboxylase inhibitors. 1. alpha- and beta-substituted histidine analogues.
    DeGraw JI; Engstrom J; Ellis M; Johnson HL
    J Med Chem; 1977 Dec; 20(12):1671-4. PubMed ID: 592333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of bacterial glutamate decarboxylase by tricarboxylic acid cycle intermediates.
    Gerig JT; Kwock L
    FEBS Lett; 1979 Sep; 105(1):155-7. PubMed ID: 385341
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitors of polyamine biosynthesis VI: 2,5-Diamino-2-(cyanomethyl) pentanoic acid, a potential irreversible inhibitor of ornithine decarboxylase.
    Abdel-Monem MM; Mikhail EA
    J Pharm Sci; 1978 Aug; 67(8):1174-5. PubMed ID: 671262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity in enzyme inhibition. 3. Synthesis of 5-substituted 2,2-dimethyl-4-imidazolidinones as inhibitors of tyrosine decarboxylase and histidine decarboxylase.
    Smissman EE; Inloes RL; El-Antably S; Shaffer PJ
    J Med Chem; 1976 Jan; 19(1):161-3. PubMed ID: 173851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective irreversible inhibition of mammalian histidine decarboxylase by alpha-chloromethyl histidine [proceedings].
    Lippert B; Bey P; Dorsselaer VA; Vevert JP; Danzin C; Ribereau-Gayon G; Jung MJ
    Agents Actions; 1979 Apr; 9(1):38-9. PubMed ID: 463697
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of five N-derivatives of 1,2,3,4-tetrahydroisoquinoline and three N alpha terminal histidine peptides as potential gastric histidine decarboxylase inhibitors.
    Agostini O; Bacciarelli C; Bonacchi G; Boni P; Castellucci A; Fedi M
    Boll Chim Farm; 1983 Feb; 122(2):86-95. PubMed ID: 6871041
    [No Abstract]   [Full Text] [Related]  

  • 17. Attempted inhibition of histidine decarboxylase with beta-alkyl analogues of histidine.
    Kelley JL; Miller CA; McLean EW
    J Med Chem; 1977 May; 20(5):721-3. PubMed ID: 853508
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of histidine-decarboxylase inhibitors on gastric acid secretion in the rat.
    Castellucci A; Megazzini P
    Arzneimittelforschung; 1976; 26(1):62-5. PubMed ID: 947180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of two inhibitors of histidine decarboxylase on gastric secretion in the rat.
    Megazzini P; Bacciarelli C
    Arzneimittelforschung; 1977; 27(3):620-3. PubMed ID: 577431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibition of ornithine decarboxylase by beta,gamma unsaturated substrate analogs.
    Relyea N; Rando RR
    Biochem Biophys Res Commun; 1975 Nov; 67(1):392-8. PubMed ID: 1201030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.